Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania

Tom Parks, Mariana Mirabel, Joseph Kado, Kathryn Auckland, Jarosław Nowak, Anna Rautanen, Alexander J. Mentzer, Éloi Marijon, Xavier Jouven, Mai Ling Perman, Tuliana Cua, John Kauwe, John Allen, Henry M. Taylor, Kathryn Robson, Charlotte M. Deane, Andrew C. Steer, Adrian V. S. Hill, Lori Allen, M. David Allen, Corinne Braunstein, Samantha Colquhoun, Aurélia Jewine, Maureen Ah Kee, R. Uday Kumar, Martin Wj, Reapi L. Mataika, Marie Nadra, Shahin Nadu, Take Naseri, Baptiste Noël, Nathalie Simon, Brenton WardNature Communications 2017 · DOI

Abstract

The indigenous populations of the South Pacific experience a high burden of rheumatic heart disease (RHD). Here we report a genome-wide association study (GWAS) of RHD susceptibility in 2,852 individuals recruited in eight Oceanian countries. Stratifying by ancestry, we analysed genotyped and imputed variants in Melanesians (607 cases and 1,229 controls) before follow-up of suggestive loci in three further ancestral groups: Polynesians, South Asians and Mixed or other populations (totalling 399 cases and 617 controls). We identify a novel susceptibility signal in the immunoglobulin heavy chain (IGH) locus centring on a haplotype of nonsynonymous variants in the IGHV4-61 gene segment corresponding to the IGHV4-6102 allele. We show each copy of IGHV4-6102 is associated with a 1.4-fold increase in the risk of RHD (odds ratio 1.43, 95% confidence intervals 1.27-1.61, P=4.1 × 10<sup>-9</sup>). These findings provide new insight into the role of germline variation in the IGH locus in disease susceptibility.

Introduction

Rheumatic Heart Disease (RHD) is a devastating condition triggered by an autoimmune-like response to Streptococcus pyogenes (Group A Strep). While most individuals recover from strep throat without long-term complications, approximately 5–6% develop acute rheumatic fever, which can progress to permanent heart valve scarring and premature death. Despite affecting over 16 million people globally—disproportionately impacting developing nations and indigenous populations—the genetic basis for RHD susceptibility has remained poorly understood. This study presents the first large-scale genome-wide association study (GWAS) for RHD, focusing on the high-burden, understudied populations of Oceania.

Study Design and Population Structure

The researchers recruited a primary collection of 3,412 DNA samples from eight Oceanian countries, including Fiji, New Caledonia, Vanuatu, and Samoa. After rigorous quality control, the final analysis set comprised 2,852 individuals (1,006 cases and 1,846 controls).

Geographic distribution and population structure of the study cohort in Oceania. Panel (a) shows recruitment sites and sample sizes. Panels (b) and (c) illustrate the ancestry stratification and admixture analysis used to group participants.

Given the region's significant genetic diversity, the team employed a multi-stage approach. Participants were stratified into four ancestral groups—Melanesian, Polynesian, South Asian (Fijian Indian), and Mixed—using principal component analysis (PCA). To improve the accuracy of genetic mapping in these populations, the researchers developed a custom reference panel by performing low-coverage whole-genome sequencing on 64 Melanesian individuals, supplementing the standard 1000 Genomes Project data. Linear Mixed Models (LMM) were then used to account for complex family relationships and population structures common in island communities.

Discovery of the IGHV4-61*02 Risk Allele

The study identified a novel susceptibility signal within the immunoglobulin heavy chain (IGH) locus, a region that codes for the heavy chain of antibodies. This locus is notoriously difficult to study due to its repetitive and complex nature, often leading to its exclusion from standard GWAS.

The lead signal centered on a haplotype of nonsynonymous variants in the IGHV4-61 gene segment, specifically the IGHV4-6102 allele. The association was anchored by a lead SNP (rs11846409) with a highly significant p-value ($P = 3.6 \times 10^{-9}$). The researchers found that each copy of the IGHV4-6102 allele is associated with a 1.43-fold increase in the risk of RHD (Odds Ratio 1.43, 95% CI 1.27–1.61). Remarkably, this risk signal was consistent across different ancestral groups, including Melanesians and South Asians, suggesting a fundamental biological driver of the disease.

Structural and Clinical Significance

The risk allele involves a specific mutation that changes a Proline to an Alanine at residue 46 (P46A). Structural modeling suggests that this residue is located at the interface where the heavy and light chains of an antibody meet. This mutation likely alters how the antibody recognizes bacterial antigens or host heart proteins, potentially facilitating the "autoreactive" immune response that characterizes RHD.

Clinical validation further supported these findings. In a supplemental analysis conducted in Samoa, the strength of the genetic effect correlated with the certainty of the clinical diagnosis; the effect was most pronounced in individuals with "definite" RHD compared to those with "borderline" cases. The findings were also confirmed using gold-standard Sanger sequencing in a subset of 339 individuals.

Conclusion and Future Outlook

This study provides a crucial link between inherited antibody variation and the body's aberrant immune response to Group A Strep. By identifying a germline (inherited) variant in the IGH locus, the researchers have shown that the "starting kit" of genes an individual inherits plays a significant role in RHD susceptibility.

These results have profound implications for vaccine development. One of the primary hurdles to a Group A Strep vaccine is the risk of accidentally triggering RHD. Understanding the genetic markers of susceptibility could help researchers design safer vaccines that avoid targeting antigens recognized by these high-risk antibodies. Future work will focus on proving the exact functional mechanism in the lab and determining if this IGH signal is responsible for RHD risk in other high-burden regions, such as Sub-Saharan Africa.

Summary updated

Abstract

The indigenous populations of the South Pacific experience a high burden of rheumatic heart disease (RHD). Here we report a genome-wide association study (GWAS) of RHD susceptibility in 2,852 individuals recruited in eight Oceanian countries. Stratifying by ancestry, we analysed genotyped and imputed variants in Melanesians (607 cases and 1,229 controls) before follow-up of suggestive loci in three further ancestral groups: Polynesians, South Asians and Mixed or other populations (totalling 399 cases and 617 controls). We identify a novel susceptibility signal in the immunoglobulin heavy chain (IGH) locus centring on a haplotype of nonsynonymous variants in the IGHV4-61 gene segment corresponding to the IGHV4-61*02 allele. We show each copy of IGHV4-61*02 is associated with a 1.4-fold increase in the risk of RHD (odds ratio 1.43, 95% confidence intervals 1.27-1.61, P=4.1 × 10<sup>-9</sup>). These findings provide new insight into the role of germline variation in the IGH locus in disease susceptibility.
BibTeX
@inproceedings{parks2017association,
  author = {Tom Parks and Mariana Mirabel and Joseph Kado and Kathryn Auckland and Jarosław Nowak and Anna Rautanen and Alexander J. Mentzer and Éloi Marijon and Xavier Jouven and Mai Ling Perman and Tuliana Cua and John Kauwe and John Allen and Henry M. Taylor and Kathryn Robson and Charlotte M. Deane and Andrew C. Steer and Adrian V. S. Hill and Lori Allen and M. David Allen and Corinne Braunstein and Samantha Colquhoun and Aurélia Jewine and Maureen Ah Kee and R. Uday Kumar and Martin Wj and Reapi L. Mataika and Marie Nadra and Shahin Nadu and Take Naseri and Baptiste Noël and Nathalie Simon and Brenton Ward and Brenton Ward},
  title = {{Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania}},
  booktitle = {Nature Communications},
  year = {2017},
  doi = {10.1038/ncomms14946},
}
Figure